The Morally Uncomfortable Global Drug Gap

  title={The Morally Uncomfortable Global Drug Gap},
  author={Jillian Clare Cohen-Kohler},
  journal={Clinical Pharmacology \& Therapeutics},
  • J. C. Cohen-Kohler
  • Published 1 November 2007
  • Political Science, Medicine
  • Clinical Pharmacology & Therapeutics
Pharmaceuticals are one of the cornerstones of human development as their rational consumption can reduce morbidity and mortality rates and enhance the quality of life. Pharmaceuticals have curative and therapeutic qualities, so they cannot be considered as ordinary products. In line with this, ensuring public policy fosters access to medicines demands thoughtful and careful consideration, as it is often about whether a patient lives or dies. Despite the flow of international aid for… 
Herbal Remedies in Resource‐poor Settings: Friend or Foe?
Identification of the most oft-used TM agents in resource-poor settings will serve to inform future research, which may in turn help avoid compromising antiretroviral therapy efficacy in HIV-infected patients.
The biosocial dynamics of tuberculosis
A very broad historical look at the changing trends in the behaviour of the disease in communities worldwide and the attitudes of the various communities to the Disease in their midst is needed to understand past mistakes and to make sure the authors do not make the same mistakes now and in the future.
Essential Medicines and Pharmacy Services
The development of the World Health Organization Model List of Essential Medicines and the Model Formulary for Children are sentinel achievements in providing governments and nongovernmental organizations with useful tools upon which to base national drug policy.
Access to Medicines – More Than Just Affordability
This chapter focuses on the resources building block of the health system, in relation to availability, accessibility, affordability, acceptability and quality of medicines forChildren, and considers the impact of market forces, innovation, transparency and donors’ agenda and funding on optimal access to medicines for children.
Patent rights and essential medicines in developing countries: is access compromised for innovation in Nigeria?
This commentary seek s to debate this Health policy issue under the statements: “Patent rights are important for drug companies to i nduce innovation and research and development” and recommendations are made to guide Nigerian policy.
Beyond access to medicines: Eliciting high–income country support for a new global health research and development paradigm
The report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), published in 2012, marks the most recent milestone in the search of a new RD a more sustainable and efficient funding source for RD and direct benefits through the products of R&D into new antibiotics and vector borne diseases.
Pharmacogenomic technologies: a necessary "luxury" for better global public health?
This analysis shows that pharmacogenomic technologies do have the potential to redirect drug development and distribution so as to improve the health of vulnerable populations, and strategies should be developed to better direct their implementation towards meeting the needs and responding to the realities of populations of the developing world.
Regulatory and logistical issues influencing access to antineoplastic and supportive care medications for children with cancer in developing countries
The need for closer international collaboration to address the barriers currently impeding access to antineoplastic and supportive care medicines for children is emphasized.
Access to medicines from a health system perspective
This article proposes three essential paradigm shifts that take into account complex and dynamic relationships between medicines and other components of the health system that are schematized in a new framework proposing a health system perspective on ATM.
Availability and Choice of Antimalarials at Medicine Outlets in Ghana: The Question of Access to Effective Medicines for Malaria Control
An indicator‐based assessment of availability and choice of antimalarials at 130 licensed medicine outlets in Ghana discusses how the choice of an antimalarial to dispense conforms to recommendations of the national policy for malaria therapy.


Global health and moral values
Patents and medicines: the relationship between TRIPS and the human right to health
The extent to which TRIPS encompasses flexibility for developing countries to be able to foster better access to medicines is examined and the ways in which the relationship between human rights and intellectual property can be improved in international law are considered.
WTO Deference to National Health Policy: Toward an Interpretive Principle
The WTO system has come to treat protection for health as a de facto interpretive principle when disputes arise over members' treaty obligations, and decision-makers have preferred the path of deference to members' varied policy choices.
The Truth About the Drug Companies: How They Deceive Us and What to Do About It
In The Truth About the Drug Companies, Dr. Angell presents the grim details of Big Pharma’s rise to power and the manipulative and downright devious tricks it uses to stay there.
World poverty and human rights : cosmopolitan responsibilities and reforms
  • Thomas Pogge
  • Political Science
    Ethics & International Affairs
  • 2003
Introduction.I Some Cautions About Our Moral JudgementsII Four Easy Reasons to Ignore World PovertyIII Defending Our Acquiescence in World PovertyIV Does Our New Global Economic Order Really Not Harm
The pharmaceutical industry
Has Globalization Gone Too Far
The process that has come to be called "globalization" is exposing a deep fault line between groups who have the skills and mobility to flourish in global markets and those who either don't have
The Pharmaceutical Industry
It is time for students and doctors to be trained in a more critical approach to the industry and its representatives.
toward an interpretive principle
  • J. Int. Econ. Law 5, 825–848
  • 2002